Catalog No.
RHD12603
Expression system
Mammalian Cells
Species reactivity
Human
Host species
Alpaca
Isotype
VHH-8His-Cys-tag
Clonality
Monoclonal
Target
Vascular endothelial growth factor A, VPF, VEGFA, VEGF, Vascular permeability factor, VEGF-A
Concentration
0.32 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Purified by Nickel column.
Accession
P15692
Applications
ELISA
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
SAA0902
Radiotherapy-derived engineered stem cell exosomes improve anti-glioma immunotherapy by promoting the formation of tertiary lymphoid structure and improve the release of type I interferon., PMID:40121481
Comprehensive biomarker and modeling approach to support dose finding for BI 836880, a VEGF/Ang-2 inhibitor., PMID:39402675
Antibody fragments targeting the extracellular domain of follicular stimulating hormone receptor for contraception in male dogs and cats., PMID:38875921
Impaired Testicular Function without Altering Testosterone Concentration Using an Anti-Follicular-Stimulating Hormone Receptor (Anti-FSHr) Single-Chain Variable Fragment (scFv) in Long-Tailed Macaques (Macaca fascicularis)., PMID:37508065
Pharmacodynamic and Antitumor Activity of BI 836880, a Dual Vascular Endothelial Growth Factor and Angiopoietin 2 Inhibitor, Alone and Combined with Programmed Cell Death Protein-1 Inhibition., PMID:36241203
A Structural Overview of Vascular Endothelial Growth Factors Pharmacological Ligands: From Macromolecules to Designed Peptidomimetics., PMID:34833851
VHH212 nanobody targeting the hypoxia-inducible factor 1α suppresses angiogenesis and potentiates gemcitabine therapy in pancreatic cancer in vivo., PMID:33830713
Nintedanib and a bi-specific anti-VEGF/Ang2 nanobody selectively prevent brain metastases of lung adenocarcinoma cells., PMID:32918638
Oligoclonal selection of nanobodies targeting vascular endothelial growth factor., PMID:30409071
Intraocular Penetration of a vNAR: In Vivo and In Vitro VEGF165 Neutralization., PMID:29614715
Design and characterization of MP0250, a tri-specific anti-HGF/anti-VEGF DARPin® drug candidate., PMID:29035637
Development of a novel nano-sized anti-VEGFA nanobody with enhanced physicochemical and pharmacokinetic properties., PMID:28841807
Inhibition of angiogenesis in human endothelial cell using VEGF specific nanobody., PMID:25645505
A nanobody directed to a functional epitope on VEGF, as a novel strategy for cancer treatment., PMID:24569074
The untapped potential of Gallium 68-PET: the next wave of ⁶⁸Ga-agents., PMID:23232184
Nanoantibodies for detection and blocking of bioactivity of human vascular endothelial growth factor A(165)., PMID:22817466
For research use only. Not for human or drug use.
